<?xml version="1.0" encoding="UTF-8"?>
<itemContainer xmlns="http://omeka.org/schemas/omeka-xml/v5" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://omeka.org/schemas/omeka-xml/v5 http://omeka.org/schemas/omeka-xml/v5/omeka-xml-5-0.xsd" uri="https://neomed.omeka.net/items/browse?tags=Glutathione%2F%2Achemistry%2Fmetabolism&amp;output=omeka-xml" accessDate="2026-05-17T05:12:35-04:00">
  <miscellaneousContainer>
    <pagination>
      <pageNumber>1</pageNumber>
      <perPage>40</perPage>
      <totalResults>1</totalResults>
    </pagination>
  </miscellaneousContainer>
  <item itemId="5107" public="1" featured="1">
    <itemType itemTypeId="1">
      <name>Text</name>
      <description>A resource consisting primarily of words for reading. Examples include books, letters, dissertations, poems, newspapers, articles, archives of mailing lists. Note that facsimiles or images of texts are still of the genre Text.</description>
      <elementContainer>
        <element elementId="53">
          <name>URL Address</name>
          <description/>
          <elementTextContainer>
            <elementText elementTextId="63695">
              <text>&lt;a href="http://doi.org/10.3109/10837450.2014.892130" target="_blank" rel="noreferrer noopener"&gt;http://doi.org/10.3109/10837450.2014.892130&lt;/a&gt;</text>
            </elementText>
          </elementTextContainer>
        </element>
        <element elementId="55">
          <name>Pages</name>
          <description/>
          <elementTextContainer>
            <elementText elementTextId="63697">
              <text>497–506</text>
            </elementText>
          </elementTextContainer>
        </element>
        <element elementId="56">
          <name>Issue</name>
          <description/>
          <elementTextContainer>
            <elementText elementTextId="63698">
              <text>4</text>
            </elementText>
          </elementTextContainer>
        </element>
        <element elementId="57">
          <name>Volume</name>
          <description/>
          <elementTextContainer>
            <elementText elementTextId="63699">
              <text>20</text>
            </elementText>
          </elementTextContainer>
        </element>
      </elementContainer>
    </itemType>
    <elementSetContainer>
      <elementSet elementSetId="1">
        <name>Dublin Core</name>
        <description>The Dublin Core metadata element set is common to all Omeka records, including items, files, and collections. For more information see, http://dublincore.org/documents/dces/.</description>
        <elementContainer>
          <element elementId="50">
            <name>Title</name>
            <description>A name given to the resource</description>
            <elementTextContainer>
              <elementText elementTextId="63687">
                <text>Brain-targeted delivery of doxorubicin using glutathione-coated nanoparticles for brain cancers.</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="45">
            <name>Publisher</name>
            <description>An entity responsible for making the resource available</description>
            <elementTextContainer>
              <elementText elementTextId="63688">
                <text>Pharmaceutical development and technology</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="40">
            <name>Date</name>
            <description>A point or period of time associated with an event in the lifecycle of the resource</description>
            <elementTextContainer>
              <elementText elementTextId="63689">
                <text>2015</text>
              </elementText>
              <elementText elementTextId="63690">
                <text>2015-06</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="49">
            <name>Subject</name>
            <description>The topic of the resource</description>
            <elementTextContainer>
              <elementText elementTextId="63691">
                <text>Antibiotics; Animals; *Drug Delivery Systems; Rats; Cell Line; Polylactic Acid-Polyglycolic Acid Copolymer; Blood-Brain Barrier/*metabolism; Brain cancer; Brain Neoplasms/drug therapy/metabolism; brain-targeted delivery; doxorubicin; Doxorubicin/*administration &amp; dosage/pharmacokinetics; Drug Carriers/*chemistry/metabolism; Glutathione/*chemistry/metabolism; Lactic Acid/chemistry/metabolism; Nanoparticles/*chemistry/metabolism; PLGA-PEG NP; Polyethylene Glycols/chemistry/metabolism; Polyglycolic Acid/chemistry/metabolism; Tumor; Antineoplastic/*administration &amp; dosage/pharmacokinetics</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="39">
            <name>Creator</name>
            <description>An entity primarily responsible for making the resource</description>
            <elementTextContainer>
              <elementText elementTextId="63692">
                <text>Geldenhuys Werner; Wehrung Daniel; Groshev Anastasia; Hirani Anjali; Sutariya Vijaykumar</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="41">
            <name>Description</name>
            <description>An account of the resource</description>
            <elementTextContainer>
              <elementText elementTextId="63693">
                <text>OBJECTIVES: To prepare and characterize in vitro a novel brain-targeted delivery of doxorubicin using glutathione-coated nanoparticles (NPs) for the treatment of brain cancer. METHODS: Doxorubicin-loaded NPs were prepared by the nanoprecipitation method using PLGA-COOH (dl-lactide-co-glycolide). The NPs were coated with a glutathione-PEG conjugate (PEG-GSH) in order to target delivery to the brain. The NPs were characterized via in vitro studies to determine particle size, drug release, cellular uptake, immunofluorescence study, cytotoxic assay, and in vitro blood-brain barrier (BBB) assay. RESULTS: The NPs showed a particle size suitable for BBB permeation (particle size around 200 nm). The in vitro release profile of the NPs exhibited no initial burst release and showed sustained drug release for up to 96 h. The immunofluorescence study showed the glutathione coating does not interfere with the drug release. Furthermore, in vitro BBB Transwell study showed significantly higher permeation of the doxorubicin-loaded NPs compared with the free doxorubicin solution through the coculture of rat brain endothelial (RBE4) and C6 astrocytoma cells (p \textless 0.05). CONCLUSIONS: We conclude that the initial in vitro characterization of the NPs demonstrates potential in delivering doxorubicin to cancer cells with possible future application in targeting brain cancers in vivo.</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="43">
            <name>Identifier</name>
            <description>An unambiguous reference to the resource within a given context</description>
            <elementTextContainer>
              <elementText elementTextId="63694">
                <text>&lt;a href="http://doi.org/10.3109/10837450.2014.892130" target="_blank" rel="noreferrer noopener"&gt;10.3109/10837450.2014.892130&lt;/a&gt;</text>
              </elementText>
            </elementTextContainer>
          </element>
          <element elementId="47">
            <name>Rights</name>
            <description>Information about rights held in and over the resource</description>
            <elementTextContainer>
              <elementText elementTextId="63696">
                <text>Article information provided for research and reference use only. All rights are retained by the journal listed under publisher and/or the creator(s).</text>
              </elementText>
            </elementTextContainer>
          </element>
        </elementContainer>
      </elementSet>
    </elementSetContainer>
    <tagContainer>
      <tag tagId="28210">
        <name>*Drug Delivery Systems</name>
      </tag>
      <tag tagId="250">
        <name>2015</name>
      </tag>
      <tag tagId="123">
        <name>Animals</name>
      </tag>
      <tag tagId="5251">
        <name>Antibiotics</name>
      </tag>
      <tag tagId="28832">
        <name>Antineoplastic/*administration &amp; dosage/pharmacokinetics</name>
      </tag>
      <tag tagId="28431">
        <name>Blood-Brain Barrier/*metabolism</name>
      </tag>
      <tag tagId="18025">
        <name>Brain cancer</name>
      </tag>
      <tag tagId="18234">
        <name>Brain Neoplasms/drug therapy/metabolism</name>
      </tag>
      <tag tagId="18235">
        <name>brain-targeted delivery</name>
      </tag>
      <tag tagId="1410">
        <name>Cell Line</name>
      </tag>
      <tag tagId="6226">
        <name>Doxorubicin</name>
      </tag>
      <tag tagId="28828">
        <name>Doxorubicin/*administration &amp; dosage/pharmacokinetics</name>
      </tag>
      <tag tagId="28829">
        <name>Drug Carriers/*chemistry/metabolism</name>
      </tag>
      <tag tagId="28555">
        <name>Geldenhuys Werner</name>
      </tag>
      <tag tagId="28830">
        <name>Glutathione/*chemistry/metabolism</name>
      </tag>
      <tag tagId="18244">
        <name>Groshev Anastasia</name>
      </tag>
      <tag tagId="18245">
        <name>Hirani Anjali</name>
      </tag>
      <tag tagId="18238">
        <name>Lactic Acid/chemistry/metabolism</name>
      </tag>
      <tag tagId="28831">
        <name>Nanoparticles/*chemistry/metabolism</name>
      </tag>
      <tag tagId="18222">
        <name>Pharmaceutical development and technology</name>
      </tag>
      <tag tagId="18240">
        <name>PLGA-PEG NP</name>
      </tag>
      <tag tagId="18241">
        <name>Polyethylene Glycols/chemistry/metabolism</name>
      </tag>
      <tag tagId="18242">
        <name>Polyglycolic Acid/chemistry/metabolism</name>
      </tag>
      <tag tagId="3214">
        <name>Polylactic Acid-Polyglycolic Acid Copolymer</name>
      </tag>
      <tag tagId="469">
        <name>Rats</name>
      </tag>
      <tag tagId="1167">
        <name>Sutariya Vijaykumar</name>
      </tag>
      <tag tagId="1423">
        <name>Tumor</name>
      </tag>
      <tag tagId="2060">
        <name>Wehrung Daniel</name>
      </tag>
    </tagContainer>
  </item>
</itemContainer>
